2 Wang M, Munoz J, Goy A, et al. KTE- X19 CAR T- cell therapy in relapsed or refractory mantle- cell lymphoma. N Engl J Med 2020;382:1331–42. 3 Liu E, Marin D, Banerjee P , et al. Use of CAR- Transduced natural killer cells in CD19- Positive lymphoid tumors. N Engl J Med 2020;382:545–53. 4 Sagnella SM, Yang L, Stubbs GE, et al. Cyto- Immuno- Therapy for cancer: a pathway elicited by tumor- targeted, cytotoxic Drug- Packaged bacterially derived Nanocells. Cancer Cell 2020;37:354–70. 5 Flatmark K, Torgunrud A, Fleten KG, et al. Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei. J Immunother Cancer 2021;9:e003109.